George Magrath - 18 Mar 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Chief Executive Officer
Signature
/s/ Amy Rabourn, by Power of Attorney
Issuer symbol
IRD
Transactions as of
18 Mar 2024
Net transactions value
+$49,050
Form type
4
Filing time
20 Mar 2024, 16:18:21 UTC
Previous filing
03 Nov 2023
Next filing
21 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Purchase $49,050 +25,000 +6.2% $1.96 425,000 18 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.90 to $1.99, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Exhibit List: Exhibit 24 - Power Attorney